Literature DB >> 7892419

Effect of a single dose (10 mg) of zolpidem on visual and spectral analysis of sleep in young poor sleepers.

O Benoit1, G Bouard, C Payan, P Borderies, J Prado.   

Abstract

Four non-consecutive nights of sleep were recorded in eight young volunteers complaining of chronic poor sleep. The subjects received a placebo or a 10 mg zolpidem dose prior to bedtime according to a Latin square double-blind design. All-night spectral analyses of the Cz-Pz lead were associated to the standard polysomnography. According to the visual scoring performed with the Rechtschaffen and Kales criteria, zolpidem significantly increased the stage 4 amount and reduced waking. Compared to placebo no difference in sleep stages was observed when the scoring was based on the power in the 0.7 to 4-Hz band. In zolpidem nights power was significantly reduced in the 4 to 8-Hz band during NREM (stages 2, 3 and 4) and was increased in the 2 to 4-Hz band during REM sleep. A significant reduction of fast activities over 12 Hz was observed during the first 3 h of sleep. Concerning slow wave activity, the only change noted was a significant slowing of its build-up rate at the beginning of cycle 1.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7892419     DOI: 10.1007/bf02245332

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  19 in total

1.  Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard.

Authors:  T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda
Journal:  Psychiatry Clin Neurosci       Date:  2001-06       Impact factor: 5.188

2.  The effects of ethanol on human sleep EEG power spectra differ from those of benzodiazepine receptor agonists.

Authors:  D J Dijk; D P Brunner; D Aeschbach; I Tobler; A A Borbély
Journal:  Neuropsychopharmacology       Date:  1992-11       Impact factor: 7.853

3.  Ultradian dynamics of sleep after a single dose of benzodiazepine hypnotics.

Authors:  A A Borbély; P Achermann
Journal:  Eur J Pharmacol       Date:  1991-03-19       Impact factor: 4.432

4.  A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms.

Authors:  J A Horne; O Ostberg
Journal:  Int J Chronobiol       Date:  1976

Review 5.  Hypnotics and sleep physiology: a consensus report. European Sleep Research Society, Committee on Hypnotics and Sleep Physiology.

Authors:  A A Borbély; T Akerstedt; O Benoit; F Holsboer; I Oswald
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

6.  Differentiating the effects of three benzodiazepines on non-REM sleep EEG spectra. A neural-network pattern classification analysis.

Authors:  A S Gevins; R K Stone; S D Ragsdale
Journal:  Neuropsychobiology       Date:  1988       Impact factor: 2.328

7.  Effect of benzodiazepine hypnotics on all-night sleep EEG spectra.

Authors:  A A Borbély; P Mattmann; M Loepfe; I Strauch; D Lehmann
Journal:  Hum Neurobiol       Date:  1985

8.  Effect of zolpidem on sleep in insomniac patients.

Authors:  J M Monti
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

9.  Dynamics of EEG slow wave activity during physiological sleep and after administration of benzodiazepine hypnotics.

Authors:  P Achermann; A A Borbély
Journal:  Hum Neurobiol       Date:  1987

10.  The dose effects of zolpidem on the sleep of healthy normals.

Authors:  L Merlotti; T Roehrs; G Koshorek; F Zorick; J Lamphere; T Roth
Journal:  J Clin Psychopharmacol       Date:  1989-02       Impact factor: 3.153

View more
  5 in total

Review 1.  Polysomnographic effects of hypnotic drugs. A review.

Authors:  L Parrino; M G Terzano
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

Review 2.  Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.

Authors:  K J Holm; K L Goa
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

3.  Sleep EEG predictors and correlates of the response to cognitive behavioral therapy for insomnia.

Authors:  Andrew D Krystal; Jack D Edinger
Journal:  Sleep       Date:  2010-05       Impact factor: 5.849

4.  Automatic analysis of single-channel sleep EEG: validation in healthy individuals.

Authors:  Christian Berthomier; Xavier Drouot; Maria Herman-Stoïca; Pierre Berthomier; Jacques Prado; Djibril Bokar-Thire; Odile Benoit; Jérémie Mattout; Marie-Pia d'Ortho
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

5.  Zolpidem reduces hippocampal neuronal activity in freely behaving mice: a large scale calcium imaging study with miniaturized fluorescence microscope.

Authors:  Tamara Berdyyeva; Stephani Otte; Leah Aluisio; Yaniv Ziv; Laurie D Burns; Christine Dugovic; Sujin Yun; Kunal K Ghosh; Mark J Schnitzer; Timothy Lovenberg; Pascal Bonaventure
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.